Anidulafungin versus Fluconazole for Invasive Candidiasis
Annette C. Reboli(Cooper Medical School of Rowan University), Thomas J. Walsh(Cornell University), David S. Krause, Stanley W. Chapman(University of Mississippi), Deepali Kumar(University Health Network), Daniel H. Kett(University of Miami), Michele Wible, Robert F. Betts(University of Rochester), Peter G. Pappas(University of Alabama at Birmingham), Beth P. Goldstein, Jennifer Schranz, Coleman Rotstein(Hamilton Health Sciences)
Cited by 896
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
|Clinical Infectious Diseases|2005|3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k